文献速递血栓与止血白血病

全局凝血试验检测儿童急性淋巴细胞白血病早期促血栓状态

Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia.
PubMed 文献 · J Thromb Haemost · 2024-06-17

研究纳入15例急性淋巴细胞白血病(ALL)患儿和15例健康对照,在AIEOP-BFM方案诱导治疗(IT)不同时间点用全局凝血试验(GCA)评估止血状态。结果显示,基于血栓动力学分析仪(TD)的内源性凝血酶潜能和纤维蛋白凝块形成速率在IT第8至12天即显著升高(P < .01),且发生血栓并发症的5例患儿在临床表现前第8至12天即显示更高的内源性凝血酶潜能(P < .05)。作者认为GCA可早期捕获促血栓变化,若获证实可据此制定血栓预防策略。

要点

  • 在ALL患儿IT期间,TD测得的内源性凝血酶潜能第8至12天即显著升高(P < .01),并持续上升。
  • 发生血栓并发症的5例患儿在IT第8至12天即显示显著更高的内源性凝血酶潜能(P < .05)。
  • 纤维蛋白凝块形成速率(凝块生长静止速率)第8至12天显著升高(P < .01)。

核心结论

  • GCA可早期捕获ALL患儿IT期间的促血栓变化;若获证实,该策略将允许对静脉血栓栓塞风险最高的ALL患儿制定个体化血栓预防方案。

研究设计与样本

  • 研究纳入15例ALL患儿和15例健康对照,在AIEOP-BFM方案诱导治疗(IT)不同时间点进行分析。
  • 检测包括促血栓生物标志物、天然抗凝蛋白、体内凝血酶生成(TG)标志物,以及体外TG(采用校准自动血栓图法、自动ST Genesia和血栓动力学分析仪TD),TD还测量纤维蛋白凝块形成。

主要发现

  • 与常规凝血试验和体内TG标志物不同,体外GCA检测到IT期间促血栓变化增加。
  • TD测得的内源性凝血酶潜能(以TG表示)在IT第8至12天即较治疗前显著升高(P < .01),并在IT期间持续升高。
  • 纤维蛋白凝块形成速率(凝块生长静止速率)在IT第8至12天显著升高(P < .01)。
  • 发生血栓并发症的5例患者中,ST Genesia和TD两种GCA均显示内源性凝血酶潜能极早期(第8至12天,P < .05)即显著更高,远早于临床表现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pediatric patients with acute lymphoblastic leukemia (ALL) are at highest risk of venous thromboembolism during the induction therapy (IT). These events are not predictable by conventional coagulation assays. OBJECTIVES: To investigate the utility of global coagulation assays (GCAs) for assessing the hemostatic state in children with ALL during IT. METHODS: We included children with ALL (n = 15) and healthy controls (n = 15). Analyses were performed at different time points during IT of the AIEOP-BFM protocols. In addition to prothrombotic biomarkers, natural anticoagulant proteins, and in vivo thrombin generation (TG) markers, ex vivo TG was measured using the gold standard calibrated automated thrombogram method, automated ST Genesia, and thrombodynamics analyzer (TD). The latter also provided measurement of fibrin clot formation. RESULTS: Different from conventional coagulation assays and in vivo TG markers, ex vivo GCAs detected increasing prothrombotic changes during IT. Particularly, TG measured with TD as expressed by endogenous thrombin potential was already significantly elevated at days 8 to 12 (P < .01) and continued to increase during IT compared with prior to beginning treatment, indicating a very early shift toward a procoagulant state. A similar pattern was observed for the rate of fibrin clot formation (stationary rate of clot growth: P < .01 at days 8-12). Remarkably, in patients developing thrombotic complications (n = 5), both GCAs, ST Genesia and TD, showed a significantly higher endogenous thrombin potential very early (already at days 8-12, P < .05), well before clinical manifestation. CONCLUSION: GCAs capture prothrombotic changes early during IT in ALL pediatric patients. If confirmed, this approach will allow tailoring thromboprophylaxis in children with ALL at highest risk for venous thromboembolism.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Betticher C, Bertaggia Calderara D, Matthey-Guirao E, et al. Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia. J Thromb Haemost. 2024. PMID: 38897386. doi:10.1016/j.jtha.2024.05.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。